Harvard Bioscience (HBIO) Divestments (2013 - 2023)
Harvard Bioscience's (HBIO) quarterly Divestments came in at $512000.0 in Q1 2023, up 2944.44% quarter-over-quarter from -$18000.0 in Q4 2019.
Powered by 
Analysis
Harvard Bioscience (HBIO) Divestments (2013 - 2023) Analysis & Trends
Harvard Bioscience (HBIO) has reported Divestments for 5 consecutive years, with $512000.0 the latest figure, recorded in Q1 2023.
- On a quarterly basis, Divestments changed N/A year-over-year to $512000.0 in Q1 2023; TTM through Dec 2023 was $512000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $512000.0, changed N/A from the prior year.
- Divestments was $512000.0 for Q1 2023 at Harvard Bioscience, up from -$18000.0 in the prior quarter.
- Over five years, Divestments peaked at $1.0 million in Q2 2019 and troughed at -$18000.0 in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.32 Bn | 219.25 Bn | 8.34 Bn | - |
| 2 | Danaher | 142.33 Bn | 137.98 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 40.40 Bn | 38.64 Bn | 1.04 Bn | - |
| 4 | Illumina | 30.71 Bn | 29.54 Bn | 770.00 Mn | - |
| 5 | Revvity | 13.65 Bn | 12.62 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 1.42 Mn |
| 7 | Bio-Rad Laboratories | 9.99 Bn | 8.37 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.22 Bn | 8.21 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 8.71 Bn | 8.15 Bn | 112.50 Mn | - |
| 10 | Harvard Bioscience | 35.61 Mn | 29.11 Mn | 12.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 512,000.00 |
| Dec 31, 2019 | -18,000.00 |
| Jun 30, 2019 | 1.02 Mn |
| Jun 30, 2018 | 24,000.00 |
| Mar 31, 2018 | 15.73 Mn |
| Mar 31, 2014 | 1.80 Mn |
| Dec 31, 2013 | 75,000.00 |